Want to see NZ:OCA full AI Analyst Report?
Top Page
Oceania Healthcare
(Sydney:OCA)
Select Model
Select Model
Rating:50Neutral
Price Target:
$0.71
Action:N/A
Date:10/05/26
The score is held back primarily by the sharp recent earnings and revenue deterioration and a weak technical trend (price below key moving averages with negative MACD). These are partially offset by strong recent operating and free cash flow and an improving leverage profile, but valuation metrics are a major drag due to the extremely high P/E and no provided dividend yield.
Positive Factors
Strong cash generation
Sustained positive cash generation gives Oceania financial flexibility to fund development, reduce debt, and support operations without relying entirely on external capital. The 2026 step-up in operating and free cash flow provides resilience even though accounting earnings were near break-even.
Negative Factors
Material revenue deterioration
The latest revenue contraction indicates weaker top-line momentum across Oceania’s operating and property activities, following an already stagnant prior year. A sustained slowdown in sales, resales, or care income would reduce the base available to absorb fixed costs and support future development.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong cash generation
Sustained positive cash generation gives Oceania financial flexibility to fund development, reduce debt, and support operations without relying entirely on external capital. The 2026 step-up in operating and free cash flow provides resilience even though accounting earnings were near break-even.
Read all positive factors
Oceania Healthcare (OCA) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$514.20M
Dividend Yield4.16%
Average Volume (3M)476.92K
Price to Earnings (P/E)3525.0
Beta (1Y)1.01
Revenue Growth2.52%
EPS Growth-99.52%
CountryNZ
Employees2,246
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)<0.01
Shares Outstanding724,231,000
10 Day Avg. Volume514,441
30 Day Avg. Volume476,920
Financial Highlights & Ratios
PEG Ratio-35.17
Price to Book (P/B)0.43
Price to Sales (P/S)1.90
P/FCF Ratio3.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.09
Revenue Forecast (FY)$657.11M
Oceania Healthcare Business Overview & Revenue Model
Company Description
Oceania Healthcare Limited, headquartered in Auckland, New Zealand, owns and operates a network of retirement villages and aged care facilities across the country. The company's business activities are categorized into three primary segments: Care...
How the Company Makes Money
Oceania Healthcare makes money primarily through a combination of (1) retirement village and property-related cash flows and (2) care and ancillary service income.
1) Retirement living (village) revenue: A key earnings driver is the development a...
Oceania Healthcare Financial Statement Overview
Summary
Income Statement
42
Neutral
Balance Sheet
63
Positive
Cash Flow
74
Positive
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 267.14M | 260.57M | 265.46M | 247.18M | 231.14M |
| Gross Profit | 45.03M | 260.57M | 265.46M | 46.51M | 38.61M |
| EBITDA | 4.00M | 68.05M | 63.35M | 53.36M | 88.31M |
| Net Income | 119.00K | 30.41M | 31.47M | 15.45M | 61.13M |
Balance Sheet | |||||
| Total Assets | 3.08B | 2.94B | 2.78B | 2.54B | 2.20B |
| Cash, Cash Equivalents and Short-Term Investments | 16.59M | 7.59M | 7.49M | 7.44M | 9.74M |
| Total Debt | 526.81M | 638.31M | 651.72M | 558.39M | 390.03M |
| Total Liabilities | 1.90B | 1.84B | 1.76B | 1.58B | 1.25B |
| Stockholders Equity | 1.18B | 1.10B | 1.03B | 962.26M | 948.84M |
Cash Flow | |||||
| Free Cash Flow | 140.01M | 70.47M | 33.36M | 15.05M | 49.24M |
| Operating Cash Flow | 157.80M | 110.28M | 85.37M | 70.21M | 105.53M |
| Investing Cash Flow | -33.42M | -100.31M | -161.25M | -219.60M | -218.82M |
| Financing Cash Flow | -115.38M | -9.86M | 75.92M | 147.09M | 43.13M |
Oceania Healthcare Technical Analysis
Negative
―
Price Trends
0.77
Negative
0.75
Negative
0.77
Negative
Market Momentum
-0.01
Positive
36.01
Neutral
4.76
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NZ:OCA, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 0.74, equal to the 50-day MA of 0.77, and equal to the 200-day MA of 0.77, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 36.01 is Neutral, neither overbought nor oversold. The STOCH value of 4.76 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NZ:OCA.
Oceania Healthcare Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $45.49M | 16.07 | ― | 3.60% | 17.86% | 20.79% | |
66 Neutral | $1.76B | 5.65 | 8.89% | 2.43% | 14.09% | -18.30% | |
63 Neutral | $34.15M | 0.03 | ― | ― | 29.55% | -11.97% | |
56 Neutral | $1.83B | -10.88 | -4.17% | 3.15% | 11.86% | 72.99% | |
56 Neutral | $114.80M | 12.16 | ― | 4.23% | 14.16% | 34.82% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | $514.20M | 3,525.00 | 0.02% | 4.16% | 2.52% | -99.52% |
* Healthcare Sector Average
NZ:OCA
Oceania Healthcare
0.70
-0.02
-2.78%
NZ:RYM
Ryman Healthcare
1.80
-1.09
-37.67%
NZ:SUM
Summerset Group Holdings Limited
7.04
-4.01
-36.26%
NZ:PHL
Promisia Healthcare Limited
0.65
0.22
50.00%
NZ:TAH
Third Age Health Services Limited
4.46
0.03
0.72%
NZ:RAD
Radius Residential Care Ltd
0.40
0.06
18.34%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.